FDA approves Avastin for advanced cervical cancer

The US Food and Drug Administration (FDA) has approved a new use for the targeted therapy drug, Avastin (bevacizumab). The new use is for cervical cancer that has not improved with treatment, has come back after treatment, or has spread to other parts of the body. It’s to be taken along with chemotherapy drugs. Avastin works by interfering with blood vessels that help cancer grow. It is already used to treat certain types of colon, kidney, lung, and brain cancer. Read more here.